FDA Orange Book · active-ingredient family
Triamcinolone diacetate
Triamcinolone diacetate: 4 brands, 4 generics; generic available.
Generic availableHas discontinued products
Generic status & protection
Generic available: 4 ANDA applications approved.
Brands (NDA)
4
Generics (ANDA)
4
Listed patents
0
Presentations
8
Brand (NDA) products
Originator applications
- ARISTOCORTRLDFOSUN PHARMANDA 012802—
Approved strengths under this FDA application. Strength Dosage form Route Status TE 40MG/ML INJECTABLE INJECTION Discontinued — - FOSUN PHARMANDA 011685—
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG/ML INJECTABLE INJECTION Discontinued — - ASTELLASNDA 011960—
Approved strengths under this FDA application. Strength Dosage form Route Status TE 2MG/5ML SYRUP ORAL Discontinued — - DELCOR ASSET CORPNDA 012515—
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 4MG BASE/5ML SYRUP ORAL Discontinued —
Generic (ANDA) products (4)
Abbreviated applications
- TRIAMCINOLONE DIACETATEEPIC PHARMA LLCANDA 085122—
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG/ML INJECTABLE INJECTION Discontinued — - TRIAMCINOLONE DIACETATEEPIC PHARMA LLCANDA 086394—
Approved strengths under this FDA application. Strength Dosage form Route Status TE 40MG/ML INJECTABLE INJECTION Discontinued — - TRIAMCINOLONE DIACETATEWATSON LABSANDA 084072—
Approved strengths under this FDA application. Strength Dosage form Route Status TE 40MG/ML INJECTABLE INJECTION Discontinued — - TRIAMCINOLONE DIACETATEWATSON LABSANDA 085529—
Approved strengths under this FDA application. Strength Dosage form Route Status TE 40MG/ML INJECTABLE INJECTION Discontinued —
Listed patents
Orange Book patent file
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Triamcinolone diacetate: frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Related FDA reference tools
- FDA Purple BookLicensed biologics, biosimilars, interchangeables, BLA records, and exclusivity dates.
- FDA BiosimilarsFDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.
